PLK1 and graft versus host disease: At 8 weeks after transplantation, about 90% of mice transplanted with human PBMNCs alone (GVHD group) died, while the majority of mice transplanted with naïve MSCs (80%), SHC-MSCs (90%), and PLK1-overexpressing MSCs (90%) survived (Fig. 4c).